6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      RAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study investigated whether inhibiting late Na(+) current by using ranolazine improved diastolic function in patients with heart failure with preserved ejection fraction (HFpEF).

          Related collections

          Author and article information

          Journal
          JACC Heart Fail
          JACC. Heart failure
          2213-1787
          2213-1779
          Apr 2013
          : 1
          : 2
          Affiliations
          [1 ] Department of Cardiology and Pneumology, Georg-August-University, Göttingen, Germany. Electronic address: lmaier@med.uni-goettingen.de.
          [2 ] Gilead Sciences, Inc., Foster City, California.
          [3 ] Department of Cardiology and Pneumology, Georg-August-University, Göttingen, Germany.
          Article
          S2213-1779(13)00038-3
          10.1016/j.jchf.2012.12.002
          24621836
          9250bb08-1849-4439-959b-f10b30d70e09
          Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

          Comments

          Comment on this article